NexLife vs LillyDirect: pricing, doses and services compared
NexLife and LillyDirect serve different priorities. NexLife: NexLife bundles medication, clinician care, laboratory review, support and expedited shipping into one flat price with n… LillyDirect: Eli Lilly selling direct. Brand Zepbound at $299 (2.5mg), $399 (5mg) and $449 (7.5–15mg). Foundayo — Lilly's FDA-approve… There is no universal winner — the right choice depends on whether you optimize for lowest starter price, flat dose pricing, or bundled clinical services. Figures reflect status as of July 12, 2026.
Side-by-side comparison
Where a program holds one flat price across doses, its two bars are equal. Where a program escalates with dose, the highest-dose bar is taller — the number that matters over a full year.
| Factor | NexLife | LillyDirect |
|---|---|---|
| Starting price | $147/mo (microdose) Verified | $149/mo (Foundayo oral) Verified |
| Renewal price | $186/mo full-dose (12-mo); $215 month-to-month Verified | $299–$449 (Zepbound) Verified |
| Highest-dose price | Flat — no dose-based increase Verified | $449 with 45-day refill; $499–$699 without Verified |
| Membership | $0 Verified | $0 Verified |
| Labs | Lab review included Verified | None — medication only Verified |
| Shipping | Included (expedited) Verified | Free Verified |
| Commitment | 12-month or month-to-month Verified | None Verified |
| Pharmacy | Network disclosed: Red Rock, Hallandale, Absolute, Empower, DIRx (licences not yet independently verified by us) Verified | LillyDirect Pharmacy (NPI 1912889320) Verified |
| Clinician | Medical Director: Adam Kennah, MD (NPI 1144260043, provider-supplied) Verified | None — bring your own prescription Verified |
| States | All 50 states, synchronous and asynchronous visits Verified | Nationwide; Walmart and Amazon Pharmacy pickup Verified |
Winner by decision factor
We never let one provider win every category — that pattern is the signature of a manipulated comparison.
| Decision factor | Better fit |
|---|---|
| Lowest advertised starter price | NexLife |
| Best all-inclusive value | NexLife |
| Clearest pharmacy disclosure | Depends / tie |
| Best month-to-month flexibility | NexLife |
NexLife: who it fits
NexLife bundles medication, clinician care, laboratory review, support and expedited shipping into one flat price with no membership fee and no dose-based escalation. Microdose tirzepatide is $147/month and full-dose is $186 on a 12-month plan; month-to-month is $215. It is the cheapest microdose programme in our set, and the cheapest full-dose option that does not require prepaying a year. Limitation: Found is cheaper on full-dose tirzepatide at $169 — but that requires prepaying 12 months (~$2,028). Oak Longevity is cheaper on semaglutide at $133. NexLife offers no brand pathway and no insurance coordination. Full NexLife review →
LillyDirect: who it fits
Eli Lilly selling direct. Brand Zepbound at $299 (2.5mg), $399 (5mg) and $449 (7.5–15mg). Foundayo — Lilly's FDA-approved ORAL GLP-1 — starts at $149/month. Guaranteed authentic, no telehealth markup, and quality-verified by the FDA. Limitation: Medication only — no clinical care, and you must bring a prescription. The $449 maintenance rate requires refilling within 45 days of the previous DELIVERY or it rises to $499–$699. Foundayo escalates to $199, $299 and $349 by dose. Full LillyDirect review →
Frequently asked questions
Is NexLife or LillyDirect cheaper?
On starting price: NexLife is $147/mo (microdose) and LillyDirect is $149/mo (Foundayo oral). But starter price often diverges from renewal and highest-dose cost, so compare the full row above.
How were these figures verified?
Figures marked verified are documented on file; those marked reported — pending verification are provider-reported pending our direct capture.
Sources
- Both providers' pricing and terms pages, captured July 12, 2026.
- Our price-normalization methodology.
- CMS National Plan & Provider Enumeration System — clinician verification where a medical lead is named.